Sichuan Hengkang Technology was established in 2004, with its own independent research and development center (Sichuan Argal) and experienced research and development center. The company specializes in the production of advanced chiral pharmaceutical intermediates, nitrogen heterocyclic compounds, amino acids and amino acid derivatives. Currently, it has developed more than 200 varieties in five major series (chiral piperidine series, chiral piperazine series, chiral pyrrolidine series, other chiral nitrogen heterocyclic series, protected amino acids and amino acid derivatives series), with an annual output of over 200 tons.
The company has abundant customer resources and has cooperated with multinational pharmaceutical and chemical giants such as Lonza, Thermo Fisher Scientific, TEVA, MSN, as well as domestic listed pharmaceutical companies such as Asymchem, WuXi AppTec, Chongqing Porten, Phrmaron, and PharmaBlock, which have helped the rapid development of the enterprise.
more >
Year of Establishment:
2004
Total Assets(USD):
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO)
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: